Loss of Keratin 17 induces tissue-specific cytokine polarization and cellular differentiation in HPV16-driven cervical tumorigenesis in vivo

Ryan Hobbs, A. S. Batazzi, M. C. Han, P. A. Coulombe

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Despite preventive human papilloma virus (HPV) vaccination efforts, cervical cancer remains a leading cause of death in women worldwide. Development of therapeutic approaches for cervical cancer are hampered by a lack of mechanistic insight during tumorigenesis. The cytoskeletal protein Keratin 17 (KRT17;K17) is robustly expressed in a broad array of carcinomas, including in cervical tumors, where it has both diagnostic and prognostic value. In this study, we have established multiple functional roles for K17 in the promotion of cervical tumorigenesis in vivo using the established HPV16 tg mouse model for cervical squamous cell carcinoma. In HPV16 tg/+;Krt17 -/- relative to HPV16 tg/+ reference female mice, onset of cervical lesions is delayed and closely paralleled by marked reductions in hyperplasia, dysplasia and vascularization. In addition, loss of Krt17 is associated with a cytokine polarization and recruitment of effector immune cells to lesion-prone cervical epithelia. Further, we observed marked enhancement of terminal differentiation in HPV16 tg/+;Krt17 -/- cervical epithelium accompanied by a stimulation and expansion in the expression of p63, a known basal/reserve cell marker in this tissue. Altogether, the data suggest that the loss of Krt17 may foster an overall protective environment for lesion-prone cervical tissue. In addition to providing new insights into the immunomodulatory and cellular mechanisms of cervical tumorigenesis, these findings may help guide the development of future therapies including vaccines.

Original languageEnglish (US)
Pages (from-to)5653-5662
Number of pages10
JournalOncogene
Volume35
Issue number43
DOIs
StatePublished - Oct 27 2016

Fingerprint

Keratin-17
Carcinogenesis
Cytokines
Papillomaviridae
Uterine Cervical Neoplasms
Epithelium
Active Immunotherapy
Cytoskeletal Proteins
Hyperplasia
Cause of Death
Squamous Cell Carcinoma
Vaccination
Carcinoma
Neoplasms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

@article{f8c19f612f194a73bac456cde5a7281c,
title = "Loss of Keratin 17 induces tissue-specific cytokine polarization and cellular differentiation in HPV16-driven cervical tumorigenesis in vivo",
abstract = "Despite preventive human papilloma virus (HPV) vaccination efforts, cervical cancer remains a leading cause of death in women worldwide. Development of therapeutic approaches for cervical cancer are hampered by a lack of mechanistic insight during tumorigenesis. The cytoskeletal protein Keratin 17 (KRT17;K17) is robustly expressed in a broad array of carcinomas, including in cervical tumors, where it has both diagnostic and prognostic value. In this study, we have established multiple functional roles for K17 in the promotion of cervical tumorigenesis in vivo using the established HPV16 tg mouse model for cervical squamous cell carcinoma. In HPV16 tg/+;Krt17 -/- relative to HPV16 tg/+ reference female mice, onset of cervical lesions is delayed and closely paralleled by marked reductions in hyperplasia, dysplasia and vascularization. In addition, loss of Krt17 is associated with a cytokine polarization and recruitment of effector immune cells to lesion-prone cervical epithelia. Further, we observed marked enhancement of terminal differentiation in HPV16 tg/+;Krt17 -/- cervical epithelium accompanied by a stimulation and expansion in the expression of p63, a known basal/reserve cell marker in this tissue. Altogether, the data suggest that the loss of Krt17 may foster an overall protective environment for lesion-prone cervical tissue. In addition to providing new insights into the immunomodulatory and cellular mechanisms of cervical tumorigenesis, these findings may help guide the development of future therapies including vaccines.",
author = "Ryan Hobbs and Batazzi, {A. S.} and Han, {M. C.} and Coulombe, {P. A.}",
year = "2016",
month = "10",
day = "27",
doi = "10.1038/onc.2016.102",
language = "English (US)",
volume = "35",
pages = "5653--5662",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "43",

}

Loss of Keratin 17 induces tissue-specific cytokine polarization and cellular differentiation in HPV16-driven cervical tumorigenesis in vivo. / Hobbs, Ryan; Batazzi, A. S.; Han, M. C.; Coulombe, P. A.

In: Oncogene, Vol. 35, No. 43, 27.10.2016, p. 5653-5662.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Loss of Keratin 17 induces tissue-specific cytokine polarization and cellular differentiation in HPV16-driven cervical tumorigenesis in vivo

AU - Hobbs, Ryan

AU - Batazzi, A. S.

AU - Han, M. C.

AU - Coulombe, P. A.

PY - 2016/10/27

Y1 - 2016/10/27

N2 - Despite preventive human papilloma virus (HPV) vaccination efforts, cervical cancer remains a leading cause of death in women worldwide. Development of therapeutic approaches for cervical cancer are hampered by a lack of mechanistic insight during tumorigenesis. The cytoskeletal protein Keratin 17 (KRT17;K17) is robustly expressed in a broad array of carcinomas, including in cervical tumors, where it has both diagnostic and prognostic value. In this study, we have established multiple functional roles for K17 in the promotion of cervical tumorigenesis in vivo using the established HPV16 tg mouse model for cervical squamous cell carcinoma. In HPV16 tg/+;Krt17 -/- relative to HPV16 tg/+ reference female mice, onset of cervical lesions is delayed and closely paralleled by marked reductions in hyperplasia, dysplasia and vascularization. In addition, loss of Krt17 is associated with a cytokine polarization and recruitment of effector immune cells to lesion-prone cervical epithelia. Further, we observed marked enhancement of terminal differentiation in HPV16 tg/+;Krt17 -/- cervical epithelium accompanied by a stimulation and expansion in the expression of p63, a known basal/reserve cell marker in this tissue. Altogether, the data suggest that the loss of Krt17 may foster an overall protective environment for lesion-prone cervical tissue. In addition to providing new insights into the immunomodulatory and cellular mechanisms of cervical tumorigenesis, these findings may help guide the development of future therapies including vaccines.

AB - Despite preventive human papilloma virus (HPV) vaccination efforts, cervical cancer remains a leading cause of death in women worldwide. Development of therapeutic approaches for cervical cancer are hampered by a lack of mechanistic insight during tumorigenesis. The cytoskeletal protein Keratin 17 (KRT17;K17) is robustly expressed in a broad array of carcinomas, including in cervical tumors, where it has both diagnostic and prognostic value. In this study, we have established multiple functional roles for K17 in the promotion of cervical tumorigenesis in vivo using the established HPV16 tg mouse model for cervical squamous cell carcinoma. In HPV16 tg/+;Krt17 -/- relative to HPV16 tg/+ reference female mice, onset of cervical lesions is delayed and closely paralleled by marked reductions in hyperplasia, dysplasia and vascularization. In addition, loss of Krt17 is associated with a cytokine polarization and recruitment of effector immune cells to lesion-prone cervical epithelia. Further, we observed marked enhancement of terminal differentiation in HPV16 tg/+;Krt17 -/- cervical epithelium accompanied by a stimulation and expansion in the expression of p63, a known basal/reserve cell marker in this tissue. Altogether, the data suggest that the loss of Krt17 may foster an overall protective environment for lesion-prone cervical tissue. In addition to providing new insights into the immunomodulatory and cellular mechanisms of cervical tumorigenesis, these findings may help guide the development of future therapies including vaccines.

UR - http://www.scopus.com/inward/record.url?scp=84963540879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963540879&partnerID=8YFLogxK

U2 - 10.1038/onc.2016.102

DO - 10.1038/onc.2016.102

M3 - Article

VL - 35

SP - 5653

EP - 5662

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 43

ER -